Abstract
Background: Ending homelessness is a major priority of the Department of Veteran Affairs (VA), and alcohol use can be a barrier to stable housing. Clinical trials suggest that depot extended-release naltrexone (XR-NTX) is efficacious in reducing alcohol consumption among alcohol-dependent subjects. Methods: An open-label, randomized pilot study sought to examine the feasibility and effectiveness of XR-NTX versus oral naltrexone to improve alcohol consumption and housing stability among homeless, alcohol-dependent veterans at the Providence Veteran Affairs Medical Center. Results: Of 215 potential candidates approached over a 16-month recruitment period, only 15 agreed to consider study entry and 7 were randomized. The primary reasons given for refusal were not wanting an injection; fear of needles; and not wanting to change drinking habits. Only 1 participant in the XR-NTX group returned after the first injection. Three participants in the oral naltrexone group attended all 7 visits and had good outcomes. Conclusions: Although XR-NTX has demonstrated efficacy in reducing heavy drinking, limited acceptance of the injection might reduce its effectiveness among homeless, alcohol-dependent patients.
Original language | English (US) |
---|---|
Pages (from-to) | 94-96 |
Number of pages | 3 |
Journal | Substance Abuse |
Volume | 34 |
Issue number | 2 |
DOIs | |
State | Published - Apr 1 2013 |
Externally published | Yes |
Keywords
- alcohol dependence
- Homelessness
- naltrexone
- substance abuse
- veterans
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Psychiatry and Mental health
- Medicine(all)